Furthermore, SREBP-1 expression is positively associated with the clinical Gleason grades and promotes prostate cancer cell growth, migration, and castration-resistant progression, which may be mediated by the alterations of metabolic signaling networks, including androgen receptor (AR), lipogenesis, and NAPDH oxidase 5-induced oxidative stress (13). Here, SREBF1 is linked to Familial prostate cancer.